SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Misonix Inc. (MSON) -- Ignore unavailable to you. Want to Upgrade?

To: Candle stick who wrote (506)10/30/1997 6:23:00 PM
From: Peter H. Mack  Respond to of 947
 
MSON did .40 last year(3rd qtr) while simultaneously taking a compensation charge which brought the quarter to -.58. However, it is possible to do another .40 qtr. What makes it more difficult now is the additional shares.
There is no doubt that it will acheive a higher P/E ratio than it has right now (in an ugly market) and it will do better than .13. I think that the chances of previous forecasts, have diminished somewhat.
Im still long and will remain that way till fair value is reached.

regards
pm



To: Candle stick who wrote (506)10/30/1997 10:27:00 PM
From: David S.  Read Replies (1) | Respond to of 947
 
Don't get untaxed earnings confused with fully taxed earnings & consider the impact of Mentor salespeople telling potential customers to hold off buying until they're on the market.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News